Pharmaceutical Executive-07-01-2008

Pharmaceutical Executive
Leadership

July 01, 2008

Rejection is tough to take, but leaders have the drive and ability to bounce back from a setback with boundless energy

Pharmaceutical Executive
From the Editor

July 01, 2008

It's not that I disagree with the Obama and McCain healthcare proposals. It's that there's nothing actually there to disagree with

Pharmaceutical Executive
Washington Report

July 01, 2008

Rare disease treatments are riding high as patient adcovates, pharma companies, and government officials celebrate the ODA's 25th anniversary

Pharmaceutical Executive
Thought Leader

July 01, 2008

Genentech had previously been number one by a very wide margin. This year, that margin started to narrow. Novartis is now a much closer second

Pharmaceutical Executive
Columns

July 01, 2008

An innovative approach bridges the pediatric communication gap

Features
Pharmaceutical Executive

July 01, 2008

A look at some of the court cases that could actually change the pharma playing field

Pharmaceutical Executive
Columns

July 01, 2008

A strict marketing regimen will help keep your brand healthy in the digital

Pharmaceutical Executive
Features

July 01, 2008

Could gene silencing be the next great innovation in drug development? Some biotechs are betting on it.

Back Page
Pharmaceutical Executive

July 01, 2008

No, it's not as glamorous as its double-helixed offspring. But recent revelations about RNA turn even cold-eyed scientists into lyrical romantics